Keimei Yoshida

4PUBLICATIONS

23CO-AUTHORS

Medical devicesHaematological tumoursPredictive and prognostic markersTribology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 25, 2026

Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial Hypertension.

|Jun 13, 2025

Activated factor X inhibition ameliorates NF-κB-IL-6-mediated perivascular inflammation and pulmonary hypertension.

Satomi Imakiire, Keiji Kimuro, Keimei Yoshida

|May 29, 2024

Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.

Xiao-Qing Sun, Timothy Klouda, Suzanne Barnasconi

|May 25, 2023

How to incorporate tricuspid regurgitation in right ventricular-pulmonary arterial coupling.

Keimei Yoshida, Julie Birkmose Axelsen, Keita Saku

Pageof 1

Frequent Collaborators

Frances S de Man

Harm-Jan Bogaard

Xiao-Qing Sun

Janne Schwab

Anders Hammer Nielsen-Kudsk

1 joint publications

Julie Sørensen Axelsen

Asger Andersen

Ke Yuan

Kohei Masaki

Kazuya Hosokawa

Frequent Collaborators

Frances S de Man

Harm-Jan Bogaard

Xiao-Qing Sun

Janne Schwab